Mineralys Therapeutics, Inc. Common Stock MLYS
$28.27
-2.65%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-349,576,000
- Net Margin
- —
- Return on Equity
- -63.45%
- Debt-to-Equity
- 0.00
- P/E Ratio
- —
- Price / Book
- 4.54
- Price / Sales
- —
Over the trailing twelve months, Mineralys Therapeutics, Inc. Common Stock generated revenue of — and net income of $-349,576,000.
Key Stats
- Last Close
- $28.27
- Market Cap
- $2.50 billion
- 52-Week Range
- $12.59 – $47.65
- Average Volume
- 817K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.